|
|
Celyad Oncology S.A.
BRU •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeBRU
Market Capitalization12.76 mln
Float14.15 mln
Earnings Date08/02/2025
Key Fundamentals
EPS0.02
P/E13.00
ROE56.33
ROIC-30.61
ROA12.50
EBITDA, mln1.10
EV / EBITDA10.26
EV / EBIT12.61
Revenue, mln0.02
EV / Revenue537
Financial Strength
Altman Z-Score-113
Piotroski F-Score
3
/ 9
Beneish M-Score3.79
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-12.37% |
2
/ 100
 |
| 1 Month |
-9.34% |
9
/ 100
 |
| 2 Months |
-29.19% |
7
/ 100
|
| 6 Months |
28.43% |
83
/ 100
 |
| 1 Year |
-36.71% |
6
/ 100
|
|
| |
